Medicus Pharma

Medicus Pharma Ltd.是一家生物技术/生命科学公司，专注于加速新型和颠覆性治疗资产的临床开发项目。通过我们丰富的经验和广泛的行业网络，我们正在将Medicus打造成一家领先的制药公司，致力于提供更好的治疗结果并减轻疼痛和痛苦。

LoQus23 is a Dementia Discovery Fund formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.In November 2021, LoQus23 Therapeutics Ltd announced the successful closing of its £7 million extended seed round

OS Therapies (OST) is a clinical stage therapeutic company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS).In November 2020, OS Therapies announced the acquisition of all indications for OST-HER2 including Canine.In June 2021 Advaxis Inc licensing agreement with OS Therapies.In April 2021, OS Therapies announced the closing of a $6 million Series A round of funding